CUE

insider transactions

Cue Biopharma, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 90d

+136.4K

136.4K buy · 0 sell

Net value · 90d

$1000.0K

$1000.0K in · $0 out

Sentiment · 90d

Net buying

100% buying · 0% selling

Open-market trades · 90d

136.4K buy · 0 sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Buy·P
Jun 1, 26

Shao-Lee Lin KEY

Chief Executive Officer

—

45.5K sh

Own New
Buy·P
Jun 1, 26

Shao-Lee Lin KEY

Chief Executive Officer

$1000.0K

90.9K sh · $11.00

Own New
Grant·A
May 30, 26

Viola Mong Meehan

Director

$0

1.6K sh

Own New
Grant·A
May 30, 26

Daniel A. Camardo

Director

$0

1.6K sh

Own New
Grant·A
May 3, 26

Shao-Lee Lin KEY

CHIEF EXECUTIVE OFFICER

$0

655.1K sh

Own New
Grant·A
May 3, 26

Shao-Lee Lin KEY

CHIEF EXECUTIVE OFFICER

$0

327.5K sh

Own New
Grant·A
Apr 9, 26

Colin Sandercock

SVP, GENERAL COUNSEL

$0

200.0K sh

Own New
Grant·A
Apr 9, 26

Lucinda Warren

CHIEF BUSINESS OFFICER

$0

250.0K sh

Own New

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 1, 2026	Shao-Lee Lin KEY	Chief Executive Officer	Buy P	45.5K	New	—	—
Jun 1, 2026	Shao-Lee Lin KEY	Chief Executive Officer	Buy P	90.9K	New	$11.00	$1000.0K
May 30, 2026	Viola Mong Meehan	Director	Grant A	1.6K	New	—	$0
May 30, 2026	Daniel A. Camardo	Director	Grant A	1.6K	New	—	$0
May 3, 2026	Shao-Lee Lin KEY	CHIEF EXECUTIVE OFFICER	Grant A	655.1K	New	—	$0
May 3, 2026	Shao-Lee Lin KEY	CHIEF EXECUTIVE OFFICER	Grant A	327.5K	New	—	$0
Apr 9, 2026	Colin Sandercock	SVP, GENERAL COUNSEL	Grant A	200.0K	New	—	$0
Apr 9, 2026	Lucinda Warren	CHIEF BUSINESS OFFICER	Grant A	250.0K	New	—	$0

About CUE insider trading

This page tracks insider transactions for Cue Biopharma, Inc. (CUE) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.